Citadel Advisors’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,700
Closed -$131K 12748
2025
Q2
$131K Sell
10,700
-2,500
-19% -$31.4K ﹤0.01% 11085
2025
Q1
$189K Buy
13,200
+8,000
+154% +$125K ﹤0.01% 10530
2024
Q4
$82.8K Buy
5,200
+200
+4% +$3.96K ﹤0.01% 11747
2024
Q3
$120K Sell
5,000
-4,200
-46% -$96K ﹤0.01% 10879
2024
Q2
$183K Hold
9,200
﹤0.01% 10066
2024
Q1
$183K Buy
9,200
+4,200
+84% +$81.2K ﹤0.01% 10453
2023
Q4
$112K Buy
5,000
+2,500
+100% +$51.6K ﹤0.01% 10784
2023
Q3
$50.5K Buy
2,500
+2,300
+1,150% +$52.1K ﹤0.01% 11745
2023
Q2
$5.11K Sell
200
-1,200
-86% -$31.6K ﹤0.01% 13533
2023
Q1
$41.6K Buy
1,400
+100
+8% +$2.9K ﹤0.01% 12389
2022
Q4
$35.2K Buy
+1,300
New +$31.8K ﹤0.01% 12560
2020
Q4
Sell
-13,700
Closed -$455K 10900
2020
Q3
$455K Sell
13,700
-2,900
-17% -$92.7K ﹤0.01% 7466
2020
Q2
$488K Sell
16,600
-14,600
-47% -$423K ﹤0.01% 7117
2020
Q1
$840K Buy
31,200
+24,600
+373% +$735K ﹤0.01% 5634
2019
Q4
$222K Buy
+6,600
New +$239K ﹤0.01% 8033
2019
Q2
Sell
-11,600
Closed -$495K 9155
2019
Q1
$495K Buy
11,600
+5,300
+84% +$237K ﹤0.01% 6796
2018
Q4
$282K Sell
6,300
-11,100
-64% -$582K ﹤0.01% 7373
2018
Q3
$1.19M Sell
17,400
-7,200
-29% -$463K ﹤0.01% 5241
2018
Q2
$1.41M Buy
24,600
+4,700
+24% +$248K ﹤0.01% 4649
2018
Q1
$917K Buy
19,900
+15,500
+352% +$736K ﹤0.01% 4955
2017
Q4
$203K Buy
+4,400
New +$202K ﹤0.01% 7094
2016
Q3
Sell
-12,400
Closed -$403K 7231
2016
Q2
$403K Buy
12,400
+3,700
+43% +$113K ﹤0.01% 4780
2016
Q1
$250K Sell
8,700
-2,400
-22% -$63.9K ﹤0.01% 5332
2015
Q4
$371K Sell
11,100
-3,200
-22% -$99.5K ﹤0.01% 4893
2015
Q3
$407K Sell
14,300
-11,100
-44% -$387K ﹤0.01% 5087
2015
Q2
$1.03M Sell
25,400
-8,800
-26% -$395K ﹤0.01% 3926
2015
Q1
$1.68M Buy
34,200
+25,900
+312% +$1.2M ﹤0.01% 3296
2014
Q4
$377K Buy
+8,300
New +$326K ﹤0.01% 5108

Other funds holding AVNS